The drug price regulator has asked pharmaceutical companies in the country to disclose quarterly data on the amount of essential drugs — both formulations and bulk drugs — they are producing. The move is aimed at ensuring that drug makers do not stop or cut down on production of essential drugs, prices of which have been capped, or shift to combination drug versions that have been excluded from the price net.

Leave your comment

*

code